Evidence map›Paper›PMID 39712079›Full record

ReviewFrontiers in sports and active living2024

Unlocking the potential of neuromuscular electrical stimulation: achieving physical activity benefits for all abilities.

Paul W Ackermann, Robin Juthberg, Johanna Flodin

Abstract readReview
In one paragraph

Review in Frontiers in sports and active living, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paul W AckermannIntegrative Orthopedic Laboratory, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Robin JuthbergIntegrative Orthopedic Laboratory, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Johanna FlodinIntegrative Orthopedic Laboratory, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromuscular Electrical Stimulation (NMES) uses electrical impulses to induce muscle contractions, providing benefits in rehabilitation, muscle activation, and as an adjunct to exercise, particularly for individuals experiencing immobilization or physical disability. NMES technology has significantly progressed, with advancements in device development and a deeper understanding of treatment parameters, such as frequency, intensity, and pulse duration. These improvements have expanded NMES applications beyond rehabilitation to include enhanced post-exercise recovery, improved blood glucose uptake, and increased lower limb venous return, potentially reducing thrombotic risks. Despite its benefits, NMES faces challenges in user compliance, often due to improper electrode placement and discomfort during treatment. Research highlights the importance of optimizing stimulation parameters, including electrode positioning, to improve both comfort and treatment efficacy. Recent innovations, such as automated processes for locating optimal stimulation points and adaptable electrode sizes, aim to address these issues. When combined with wearable technologies, these innovations could improve NMES treatment adherence and deliver more consistent, long-term therapeutic outcomes for patients with various physical limitations. Together, these developments indicate a promising future for NMES, presenting a valuable tool to enhance the benefits of physical activity across diverse populations, from rehabilitative care to broader health and wellness applications.

Indexed as

blood flowexerciseimmobilizationmotor pointsmuscle strengtheningneuromuscular electrical stimulationvenous thromboembolism

Identifiers

PMID39712079
PMCPMC11660796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.